发明名称 NANOVECTOR BASED DRUG DELIVERY SYSTEM FOR OVERCOMING DRUG RESISTANCE
摘要 Various embodiments of the present invention provide therapeutic compositions for specifically targeting tumor cells. In some embodiments, the therapeutic compositions generally include: (1) a plurality of nanovectors; (2) one or more active agents associated with the nanovectors, where the one or more active agents have activity against the tumor cells; (3) one or more active agent enhancers associated with the nanovectors; and (4) one or more targeting agents associated with the nanovectors, where the one or more targeting agents have recognition activity for one or more markers of the tumor cells. Additional embodiments of the present invention pertain to methods of targeting tumor cells in a subject by administering one or more of the aforementioned therapeutic compositions to the subject. Further embodiments of the present invention pertain to methods of formulating the aforementioned therapeutic compositions for targeting tumor cells in a subject in a personalized manner.
申请公布号 US2015216975(A1) 申请公布日期 2015.08.06
申请号 US201314436127 申请日期 2013.03.15
申请人 WILLIAM MARSH RICE UNIVERSITY 发明人 Baskin David S.;Marcano Daniela;Sharpe Martyn A.;Tour James M.
分类号 A61K47/10;A61K47/48;A61K31/405;A61K31/517;G01N33/574;A61K31/451 主分类号 A61K47/10
代理机构 代理人
主权项 1. A therapeutic composition for targeting tumor cells, wherein the therapeutic composition comprises: a plurality of nanovectors; one or more active agents associated with the nanovectors, wherein the one or more active agents have activity against the tumor cells; one or more active agent enhancers associated with the nanovectors; and one or more targeting agents associated with the nanovectors, wherein the one or more targeting agents have recognition activity for one or more markers of the tumor cells.
地址 Houston TX US